Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2007
04/24/2007CA2289472C Excitatory amino acid receptor modulators
04/24/2007CA2268741C Uses of keratinocyte growth factor-2
04/24/2007CA2243708C Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
04/24/2007CA2188654C Modified milk growth factor
04/19/2007WO2007044713A1 Solid dispersions of opioid antagonists
04/19/2007WO2007044062A1 Bile preparations for gastrointestinal disorders
04/19/2007WO2007043939A1 Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a
04/19/2007WO2007043938A1 NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B
04/19/2007WO2007043710A1 Novel dihydropseudoerythromycin derivatives
04/19/2007WO2007043641A1 Inhibitor of transplanted islet dysfunction in islet transplantation
04/19/2007WO2007043640A1 Substance for use in treatment or prevention of hcv infection
04/19/2007WO2007043563A1 Composition for improving intestinal flora
04/19/2007WO2007043518A1 Therapeutic agent for nausea and/or vomiting
04/19/2007WO2007043457A1 Triarylcarboxylic acid derivative
04/19/2007WO2007043433A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
04/19/2007WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof
04/19/2007WO2007041964A1 The use of long half-life human recombinant soluble tumor necrosis factor alpha receptor in preparing the medicine which can prevent hepatic failure
04/19/2007WO2007041790A1 Salts of proton pump inhibitors and process for preparing same
04/19/2007WO2007041772A1 Preparation for the treatment of diarrhoea
04/19/2007WO2007009758A3 2r,4s) -4- (4-acetyl-3-hydroxy-1-piperazinyl) -n- { (1r) -1- [3, 5-bis (trifluoromethyl) phenyl] ethyl} -2- (4-fluoro-2-methylphenyl) -n-methyl-1-piperidine-carboxamide as tachykinin receptor antagonist
04/19/2007WO2007006391A3 Cynara scolymus extracts, the use thereof ans formulations containing them
04/19/2007WO2006129859A3 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia
04/19/2007WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof
04/19/2007WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
04/19/2007WO2003002065A3 Hcv e1e2 vaccine compositions
04/19/2007US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/19/2007US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid
04/19/2007US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
04/19/2007US20070088033 Diaryl Substituted Pyridinones
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
04/19/2007US20070088005 Pharmaceutical compositions for headache, migraine, nausea and emesis
04/19/2007US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/19/2007US20070087969 Wound healing and treatment of fibrosis
04/19/2007US20070087388 G protein coupled receptor
04/19/2007US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
04/19/2007DE102005049649A1 Composition, useful as e.g. nutritional supplement for the relief of gastro-intestinal tract complaints due to uptake of food containing oligosaccharide, comprises a combination of alpha-galactosidase and beta-fructofuraonosidase
04/19/2007CA2628781A1 Solid dispersions of opioid antagonists
04/19/2007CA2628035A1 Composition for improving intestinal microflora
04/19/2007CA2625773A1 Inhibition of interleukin-6 (il-6) receptor promotes pancreatic islet transplantation
04/19/2007CA2625495A1 Therapeutic agent for nausea and/or vomiting
04/19/2007CA2625055A1 Novel dihydropseudoerythromycin derivatives
04/19/2007CA2624943A1 Preparation for the treatment of diarrhoea
04/19/2007CA2624909A1 Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
04/19/2007CA2624845A1 A composition for the treatment of diabetic periodontitis
04/19/2007CA2623932A1 Prevention of dental plaque and dental calculus in animals
04/19/2007CA2621038A1 Triarylcarboxylic acid derivative
04/18/2007EP1775297A2 Adenosine receptor antagonists and methods of making and using the same
04/18/2007EP1775292A1 Salts of benzimidazole derivative with amines and process for production thereof
04/18/2007EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents
04/18/2007EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/18/2007EP1774966A1 Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients
04/18/2007EP1773816A2 Modulators of atp-binding cassette transporters
04/18/2007EP1773335A2 Nanoparticle dispersion containing lactam compound
04/18/2007EP1773329A1 Compositions and methods for treatment of colitis
04/18/2007EP1773304A2 Method of treating ileus by pharmacological activation of cholinergic receptors
04/18/2007EP1773138A1 Ena mineral bioactive solution, manufacturing method thereof and its application for the osteoporosis prevention
04/18/2007EP1589995B1 Use of avian antibodies
04/18/2007EP1583531B1 Heteroaryl-substituted pyrrolo[2, 3- b]pyridine derivatives as crf receptor antagonists
04/18/2007EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/18/2007EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
04/18/2007EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma
04/18/2007EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
04/18/2007EP1361264B1 PRODUCTS CONTAINING G(b)-GLUCAN
04/18/2007EP1335976B1 Modifier of organelle metalbolism
04/18/2007EP1137408B1 Agent for lowering endothelin levels
04/18/2007CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound
04/18/2007CN1950097A Compressed pharmaceutical compositions comprising peg and electrolytes
04/18/2007CN1950093A Oral flora-improving agent, antibacterial agent and growth promoter
04/18/2007CN1950070A Process for producing medicine
04/18/2007CN1948495A Saliva streptococcus 57.I urase gene and its urase
04/18/2007CN1948451A Health care wine and its preparation method
04/18/2007CN1948332A Glycyrrhetinic acid-30-acylamide derivatives and its use
04/18/2007CN1948331A Nitrate derivative of bile acid and its medical use
04/18/2007CN1947787A Medicine for treating adiposis hepatica and its prepn. method
04/18/2007CN1947782A Infantile health-care capsule prepn. method
04/18/2007CN1947773A Method for preparing traditional Chinese medicine Huang-Xuan-Yi-gan pills contg. day lily root with tonifying liver function
04/18/2007CN1947761A Traditional Chinese medicine granules
04/18/2007CN1947759A Traditional Chinese medicine pills for taking care of user's beauty and making user younger
04/18/2007CN1947752A Concentrated medicine pills contg. bighead atractylodes rhizome and trifoliate orange seeds and its prepn. method
04/18/2007CN1947741A Shenkun blood nourishing granule and its prepn. method
04/18/2007CN1947734A Liandan anti-inflammation soft capsule prepn., and its preparing method
04/18/2007CN1947731A Pearl products
04/18/2007CN1947723A Liquid polysaccharide, glycan nano-selenium, prepn. method and storage method thereof
04/18/2007CN1947722A Blood sugar regulator used during user having meals and its prepn. method
04/18/2007CN1947718A Cucurbitacin dispersion tablets and its prepn. method
04/18/2007CN1947707A Floated in staomach type slow-release tablets contg. berberine hydrochloide and its prepn. method
04/18/2007CN1947705A Method for producing medicine Yigan dipping-pills for tonifying liver
04/18/2007CN1947686A Salt-solution with health-care function
04/18/2007CN1311081C Stem cell differentiation
04/18/2007CN1311066C Wine for tonifying kidney and preserving health
04/18/2007CN1311065C Biological wine and production thereof
04/18/2007CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist
04/18/2007CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives
04/18/2007CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
04/18/2007CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors
04/18/2007CN1310909C Novel heteroaryl derivatives, their prepn. and use
04/18/2007CN1310906C Indole-type derivatives as inhibitors of p38 kinase
04/18/2007CN1310884C Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide
04/18/2007CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids